CLPT
CLPT
NASDAQ · Health Care

Clearpoint Neuro Inc

$15.50
+0.16 (+1.04%)
As of Aug 18, 1:20 PM ET ·
Financial Highlights (FY 2026)
Revenue
39.77M
Net Income
-27,470,348
Gross Margin
61.4%
Profit Margin
-69.1%
Rev Growth
+21.6%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 39.77M 32.70M 158.88M 142.75M
Gross Profit 24.41M 20.07M 85.53M 76.84M
Operating Income -25,990,406 -19,233,156 26.07M 25.18M
Net Income -27,470,348 -20,328,328 24.47M 21.58M
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Rev Growth +21.6% +21.6% +20.9% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 149.95M 149.95M 75.59M 72.54M
Total Equity 85.61M 85.61M 144.13M 160.68M
D/E Ratio 1.75 1.75 0.52 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,917,147 -20,244,441 37.89M 33.02M
Free Cash Flow 31.87M 21.95M